Chris Lai, founder and CEO of METiS Therapeutics

Transpa­cif­ic AI biotech makes its Se­ries A de­but — putting $86M in the bank

With the rush of AI per­me­at­ing the biotech in­dus­try, an­oth­er AI play­er is com­ing out well-or­ga­nized and flush with cash. METiS Ther­a­peu­tics an­nounced this morn­ing that it suc­cess­ful­ly put $86 mil­lion in the bank, thanks to a Se­ries A.

Two in­vest­ment firms con­nect­ed to the Chi­nese gov­ern­ment (Peo­ple’s In­sur­ance Com­pa­ny of Chi­na and Chi­na Life In­sur­ance Com­pa­ny) led the fi­nanc­ing round — and were joined by Se­quoia Cap­i­tal Chi­na, 5Y Cap­i­tal and sev­er­al oth­er in­vestors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.